Target intelligence / Profile preview

Non-specific adsorbent and chelating agent

Molecular classification
Other
01

Overview

This category represents therapeutic agents that do not interact with a specific protein receptor or enzyme but instead function through non-specific physical or chemical interactions with various substances. These agents include bile acid sequestrants, which bind bile acids in the gastrointestinal tract to interrupt enterohepatic circulation and lower cholesterol levels (StatPearls, 2023). Chelating agents, such as EDTA or penicillamine, work by forming stable, water-soluble complexes with heavy metals like lead or copper to facilitate their renal excretion (NIH, 2022). Additionally, adsorbents like activated charcoal are utilized in toxicology to bind a wide array of drugs and toxins within the gut lumen, preventing their systemic absorption (PubMed, 2021). Because these agents act via sequestration rather than traditional signal transduction, they are often used to treat metabolic disorders, poisoning, and mineral imbalances. However, their broad binding affinity can lead to significant therapeutic challenges, such as the malabsorption of essential nutrients and interference with the pharmacokinetics of other drugs. Consequently, these substances are defined by their ability to physically or chemically neutralize targets rather than by a specific biological site of action.

Other names
AdsorbentsChelating agentsBile acid sequestrantsIon-exchange resinsSequestrantsChemical antagonists
02

Mechanism of action

Binding and sequestration of target substances through physical adsorption, ion exchange, or chemical chelation to prevent systemic absorption or promote excretion.

03

Biological functions

ExcretionDetoxificationLipid metabolismIon homeostasis
04

Disease associations

HypercholesterolemiaPoisoningHeavy metal toxicityWilson diseaseHyperphosphatemiaPruritus
05

Safety considerations

Malabsorption of fat-soluble vitamins (A, D, E, K)Gastrointestinal distress and constipationNon-specific binding of co-administered medicationsElectrolyte imbalances
06

Interacting drugs

Cholestyramine

8 more in the full profile.

07

Biomarkers

Low-density lipoprotein cholesterol (LDL-C)Serum bile acidsBlood lead levelsUrinary copper excretionSerum phosphate levels

Beyond the preview

Go deeper on Non-specific adsorbent and chelating agent.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-specific adsorbent and chelating agent.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call